Research ArticleCorrespondence
A Case of Scleromyxedema Development Following Intravesical Bacillus Calmette-Guérin Administration
Reşit Yildirim, Döndü Üsküdar Cansu and Cengiz Korkmaz
The Journal of Rheumatology July 2022, 49 (7) 858-859; DOI: https://doi.org/10.3899/jrheum.211010
Reşit Yildirim
1Division of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
MDDöndü Üsküdar Cansu
1Division of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
MDRoles: Professor
Cengiz Korkmaz
1Division of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
MDRoles: Professor
REFERENCES
- 1.↵
- Boleto G,
- Avouac J,
- Allanore Y.
- 2.↵
- Garcia C,
- Jina H,
- Bergersen P,
- Chalasani V.
- 3.↵
- Ferreli C,
- Gasparini G,
- Parodi A,
- Cozzani E,
- Rongioletti F,
- Atzori L.
- 4.↵
- 5.↵
- Pérez-Jacoiste Asín MA,
- Fernández-Ruiz M,
- López-Medrano F, et al.
- 6.↵
- Macleod LC,
- Ngo TC,
- Gonzalgo ML.
- 7.↵
- Liu Y,
- Lu J,
- Huang Y,
- Ma L.
- 8.↵
- 9.↵
- Jeljeli M,
- Riccio LGC,
- Doridot L, et al.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 7
1 Jul 2022
A Case of Scleromyxedema Development Following Intravesical Bacillus Calmette-Guérin Administration
Reşit Yildirim, Döndü Üsküdar Cansu, Cengiz Korkmaz
The Journal of Rheumatology Jul 2022, 49 (7) 858-859; DOI: 10.3899/jrheum.211010